Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trial

2011 ◽  
Vol 68 (4) ◽  
pp. 1009-1016 ◽  
Author(s):  
R. Murialdo ◽  
F. Bertolotti ◽  
G. Pastorino ◽  
M. Mencoboni ◽  
M. Bergaglio ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Breast Cancer Patients ◽  
Weekly Docetaxel ◽  
Multicenter Phase ◽  
Her 2

scholarly journals Phase II Trial of Bevacizumab in Combination with Weekly Docetaxel in Metastatic Breast Cancer Patients

2006 ◽  
Vol 12 (10) ◽  
pp. 3124-3129 ◽  
Author(s):  
Bhuvaneswari Ramaswamy ◽  
Anthony D. Elias ◽  
Nicole T. Kelbick ◽  
Angela Dodley ◽  
Mark Morrow ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Breast Cancer Patients ◽  
Weekly Docetaxel

Gemcitabine/Vinorelbine in Metastatic Breast Cancer Patients Previously Treated with Anthracyclines: Results of a Phase II Trial

2003 ◽  
Vol 4 (1) ◽  
pp. 46-50 ◽  
Author(s):  
F. Lobo ◽  
J.A. Virizuela ◽  
F.J. Dorta ◽  
J. Florián ◽  
M. Lomas ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Breast Cancer Patients ◽  
Previously Treated
Sign in / Sign up

Export Citation Format

Share Document